Logo

TB Alliance and BG Medicine to Collaborate on Tuberculosis Biomarker Discovery

Feb 21, 2006

NEW YORK, Feb.21 (GenomeWeb News) - The Global Alliance for TB Drug Development and BG Medicine announced today a collaborative deal to identify biomarkers for tuberculosis drug development.

 

The collaboration will last six months, the partners said.

 

Under the deal, BG Medicine will use its proteomic and metabolomic analytical platforms to analyze samples provided by Colorado State University. TB Alliance will fund the project, with help from a grant from the Netherlands Ministry of Foreign Affairs.

 

Financial details were not provided.

 

TB Alliance is a non-profit, public-private partnership supported by the Bill and Melinda Gates Foundation and the Rockefeller Foundation.

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.